In this episode of KitePod, we delve into the fascinating world of Immunito AI, a Bengaluru-based TechBio startup that's transforming the landscape of antibody therapy. Founded by the visionary duo Dr. Aridni Shah and Trisha Chatterjee, Immunito AI leverages artificial intelligence to design cutting-edge antibodies tailored for precise and effective treatments.

Discover how their innovative platforms, imDESIGN and imRANK, are redefining traditional drug discovery by reducing development timelines by 60% and significantly cutting costs. From addressing challenges in biotechnology to creating groundbreaking solutions for diseases like cancer and autoimmune disorders, Immunito AI is a beacon of innovation in the biotech industry.

Join us as we explore their journey, challenges, and triumphs, including their $1 million seed funding, global recognitions, and ambitious mission to make antibody therapies accessible worldwide. Tune in to learn how AI and biotechnology are merging to create a future of faster, smarter, and more efficient medical solutions.

🔍 Check out the full article on Venture Kites:

https://venturekites.com/immunito-ai-antibodies-with-a-side-of-artificial-intelligence/

🌍 Discover more startup stories at Venture Kites!

https://venturekites.com/

🤝 Proudly crafted in collaboration with DORK Company.

https://dorkcompany.com/